Newborn screening for cystic fibrosis by use of a multiplex immunoassay

Clinical Chemistry

Volumn 56, Issue 3, 2010, Pages 445-450

  Lindau Shepard, Barbara A ^a   Pass, Kenneth A ^a  

^a WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; ISOPROTEIN; POLYCLONAL ANTIBODY; TRYPSINOGEN;

ARTICLE; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; GENE MUTATION; HETEROZYGOTE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NEWBORN; NEWBORN SCREENING; SENSITIVITY AND SENSIBILITY; STANDARDIZATION;

CYSTIC FIBROSIS; HUMANS; IMMUNOASSAY; INFANT, NEWBORN; NEONATAL SCREENING; PROTEIN ISOFORMS; TRYPSINOGEN;

EID: 77649218431     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.132480     Document Type: Article

References (16)

1. Crossley JR, Elliott RB, Smith PA. Dried blood spot screening for cystic fibrosis in the newborn. Lancet 1979;1:742-4.
2. Guy O, Lombardo D, Bartelt DC, Amic J, Figarella C. Two human trypsinogens: purification, molecular properties and N-Terminal sequences. Biochemistry 1978;17:1669-75.
3. Kimland M, Russick C, Marks WH, Borgstrom A. Immunoreactive anionic and cationic trypsin in human serum. Clin Chim Acta 1989;184:31-46.
4. Itkonen O, Koivunen E, Hurme M, Alfthan H, Schroder T, Stenman U-H. Time resolved immunofluorometric assays for trypsinogen 1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis. J Lab Clin Med 1990;115:712-8.
5. Wilcken B. Newborn screening for cystic fibrosis: techniques and strategies. J Inherit Metab Dis 2007;30:537-43.
6. Deam SM, Ryley HC. Enzyme immunoassay of immunoreactive trypsin in serum and blood spots. Wein Klin Wochenschr 1988;100:55-7.
7. Cabrini G, Pederzini F, Perobelli L, Mastella G. An evaluation of an enzyme linked immunoassay method for immunoreactive trypsinogen in dried blood spots. Clin Biochem 1990;23:213-9.
8. Ball CL, Montgomery MD, Bridge PJ, Lyon ME. Evaluation of the Quantase™ neonatal immunoreactive trypsinogen (IRT) screening assay for cystic fibrosis. Clin Chem Lab Med 2005;43:570-2.
9. Li L, Zhou Y, Bell CJ, Earley MC, Hannon WH, Mei JV. Development and characterization of dried blood spot materials for the measurement of immunoreactive trypsinogen. J Med Screen 2006; 13:79-84.
10. Lafont P, Guy-Crotte G, Paulin C, Galvain D, Mertani S, Figarella C, et al. A specific immunoradiometric assay of cationic trypsin(ogen) that does not recognize trypsin-alpha-1-proteinase inhibitor complex. Clin Chim Acta 1995;235:197-206.
11. Casellani C, Picci L, Scarpa M, Deshecci MC, Zanolla L, Assael BM, et al. Cystic fibrosis carriers have higher neonatal trypsinogen values than non-carriers. Am J Med Genet A 2005;135: 142-4.
12. Lecoq I, Brouard J, Laroche D, Ferec C, Travert J. Blood immunoreactive trypsinogen concentrations are genetically determined in healthy and cystic fibrosis newborns. Acta Paediatr 1999;88: 338-41.
13. Sarles J, Berthe'ZèNe P, Le Louarn C, Somma C, Perini J-M, Catheline M, Mirallié M, et al. Combing immunoreactive trypsinogen and pancreatitis-associated protein assays: a method of newborn screening for cystic fibrosis that avoids DNA analysis. J Pediatr 2005;147:302-5.
14. Bellisario R, Colinas R, Pass KA. Simultaneous measurement of antibodies to three HIV-1 antigens in newborn dried blood spot specimens using a multiplexed microsphere-based immunoassay. Early Hum Dev 2001;64:21-5.
15. 4) and thyrotrophin (TSH) from newborn dried blood spot specimens using a multiplexed fluorescent immunoassay. Clin Chem 2000;46:1422-4.
16. Colinas RJ, Bellisario R, Pass KA. Multiplexed genotyping of beta-globins variants from polymerase chain reaction-amplified newborn bloodspot DNA by hybridization with allele-specific oligodeoxynucleotides coupled to an array of fluorescent microspheres. Clin Chem 2000;46:1-3.